This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Jazz Pharmaceuticals PLC (JAZZ)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Cash and Equivalents 636.50M 387.20M 82.08M 44.79M
Receivables 124.80M 75.48M 34.37M 22.08M
Inventories 28.67M 26.52M 3.91M 5.05M
Other Current Assets 33.84M 62.37M 1.26M 279.00K
Total Current Assets 864.62M 551.57M 199.13M 74.46M
Property, Plant & Equipment, Gross 24.86M 15.06M 8.14M 6.92M
Accumulated Depreciation & Depletion 10.61M 7.78M 6.58M 6.23M
Property, Plant & Equipment, Net 14.25M 7.28M 1.56M 690.00K
Intangibles 812.40M 869.95M 14.58M 22.03M
Other Non-Current Assets 21.91M 20.24M 87.00K 335.00K
Total Non-Current Assets 1.37B 1.41B 54.44M 61.27M
Liabilities & Shareholder Equity
Total Assets 2.24B 1.97B 253.57M 135.73M
Accounts Payable 21.00M 15.89M 9.63M 7.55M
Short Term Debt 5.57M 29.69M 0.00 23.41M
Other Current Liabilities 50.34M 41.02M 7.32M 4.13M
Total Current Liabilities 204.03M 191.54M 52.87M 59.94M
Long Term Debt 544.40M 427.07M 0.00 24.63M
Deferred Income Taxes 168.50M 178.39M 0.00 0.00
Other Non-Current Liabilities 25.76M 48.20M 7.92M 20.61M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 738.66M 653.66M 7.92M 45.24M
Total Liabilities 942.69M 845.20M 60.78M 105.18M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 1.30B 1.12B 192.79M 30.55M
Common Par 6.00K 6.00K 4.00K 4.00K
Additional Paid In Capital 1.22B 1.15B 542.70M 505.41M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings 18.53M -61.30M -349.88M -474.87M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 56.68M 31.57M -31.00K 0.00
Total Capitalization 1.84B 1.55B 192.79M 55.18M
Total Equity 1.30B 1.12B 192.79M 30.55M
Total Liabilities & Stock Equity 2.24B 1.97B 253.57M 135.73M
Total Common Shares Outstanding 57.85M 58.01M 42.47M 39.96M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 58.30M 56.64M 41.50M 36.34M
Diluted Weighted Shares Outstanding 61.57M 60.20M 46.80M 39.41M
Number of Employees 810 610 431 242
Number of Part-Time Employees 0 0 0 0

JAZZ Jazz Pharmaceuticals PLC

Analysts Ratings for JAZZ

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 10 10 10 10
Moderate Buy 0 0 0 0
Hold 2 2 2 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

Brokerage Partners

JAZZ Chatter

Select the service that is right for you!

Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs